ABBV: AbbVie Inc Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 265,066.51
Enterprise Value ($M) 332,647.51
Book Value ($M) 15,436.00
Book Value / Share 8.74
Price / Book 17.17
NCAV ($M) -100,388.00
NCAV / Share -56.81
Price / NCAV -2.64

Profitability (mra)
Return on Invested Capital (ROIC) 0.14
Return on Assets (ROA) 0.08
Return on Equity (ROE) 0.91

Liquidity (mrq)
Quick Ratio 0.71
Current Ratio 0.82

Balance Sheet (mrq) ($M)
Current Assets 26,509.00
Assets 143,211.00
Liabilities 126,897.00
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 56,197.00
Operating Income 19,537.00
Net Income 11,542.00
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 22,777.00
Cash from Investing -2,344.00
Cash from Financing -19,039.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-09 13G/A Vanguard Group Inc 8.28 2.63
02-03 13G/A BlackRock Inc. 7.30 3.03

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2022-05-06 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2022-02-18 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. C. 20549 FORM 10-K (MARK ONE) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
2021-08-02 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2022-05-27 711,655 6,365,002 11.18
2022-05-26 484,276 4,811,441 10.07
2022-05-25 495,129 3,999,692 12.38
2022-05-24 361,388 5,260,488 6.87
2022-05-23 488,159 5,368,185 9.09

(click for more detail)

(click for list of largest short owners)

Similar Companies
ABT – Abbott Laboratories ADCT – Adc Telecommunications Inc


Financial data and stock pages provided by
Fintel.io